Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2003
10/28/2003US6638907 Laminin 8 and methods for its use
10/28/2003US6638736 Gene expression inhibition; cancer and neurodegenerative disease diagnosis; molecular hybridization
10/28/2003US6638522 Carrier comprising solubilizing amount of propylene glycol monoester of C6-C18 fatty acid and nonionic surfactant
10/28/2003US6638521 Oral liquid mucoadhesive compositions
10/28/2003US6638516 Strain selection of pneumococcal surface proteins
10/28/2003US6638505 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer
10/28/2003US6638499 A nitrogen group containing linkage which is attached one end with a polyoxyalkylene glycol polymer and other end is coupled with a drug; useful for drug delivery
10/28/2003CA2342309C New solid dose form of nanoparticulate naproxen
10/28/2003CA2283939C Non-antigenic branched polymer conjugates
10/28/2003CA2253796C Inhibition of matrix metalloproteases by acetylene containing compounds
10/28/2003CA2252701C Halo-substituted protein kinase c inhibitors
10/28/2003CA2037116C Hexahydrobenz ¢cd! indoles
10/23/2003WO2003087408A2 Schizophrenia associated genes
10/23/2003WO2003087406A1 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases
10/23/2003WO2003087403A2 Diagnostic and therapeutic use of a golgi protein for neurodegenerative diseases
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087368A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003WO2003087367A2 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003WO2003087364A1 Novel g protein-coupled receptor and its gene
10/23/2003WO2003087345A2 Stimulation of nerve cell regeneration
10/23/2003WO2003087333A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003WO2003087174A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
10/23/2003WO2003087139A2 Treatment of gastroparesis
10/23/2003WO2003087134A2 G-protein coupled receptor ligands and methods
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087104A1 Heterocyclic compounds
10/23/2003WO2003087103A1 Thienyl compounds
10/23/2003WO2003087102A1 Furyl compounds
10/23/2003WO2003087099A1 Imidazo-pyridine derivatives as ligands for gaba receptors
10/23/2003WO2003087096A1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament
10/23/2003WO2003087091A1 Novel crystal of quinoxalinedione derivative anhydride
10/23/2003WO2003087090A2 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003WO2003087087A2 Heterocyclic compounds and their use as modulators of p38 map kinase
10/23/2003WO2003087086A2 Substituted indoles
10/23/2003WO2003087062A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
10/23/2003WO2003087061A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003087060A1 Fredericamycin derivatives
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087040A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003087035A1 2,5-bis-diamine-'1,4! benzoquinone derivatives for the treatment of alzheimer's disease a process for their preparation and intermediates therefor
10/23/2003WO2003086462A1 c-Jun PHOSPHORYLATION INHIBITORS
10/23/2003WO2003086459A1 Methods of treatement using ctla-4 antibodies
10/23/2003WO2003086458A1 Recombinant anti-interleukin-9 antibodies
10/23/2003WO2003086440A1 Novel use of the extract of processed ginseng and saponin isolated therefrom
10/23/2003WO2003086417A1 Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system
10/23/2003WO2003086413A1 Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
10/23/2003WO2003086410A1 Pharmaceutical compositions comprising a 11-beta hydroxysteroid dehydrogenase inhibitor and a diuretic agent
10/23/2003WO2003086409A1 The use of devazepide as analgesic agent
10/23/2003WO2003086406A1 Imidazo-pyridine derivatives as ligands for gaba receptors
10/23/2003WO2003086400A1 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
10/23/2003WO2003086396A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
10/23/2003WO2003086390A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003086371A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
10/23/2003WO2003086352A1 Pharmaceutical formulation comprising melatonin
10/23/2003WO2003086351A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003WO2003086326A2 G-type peptides to ameliorate atherosclerosis
10/23/2003WO2003086325A2 Cyanamides useful as reversible inhibitors of cysteine proteases
10/23/2003WO2003086317A2 Protein a compositions and methods of use
10/23/2003WO2003086315A2 Tyrosine kinase inhibitors
10/23/2003WO2003086314A2 Tyrosine kinase inhibitors
10/23/2003WO2003086311A2 Methods for treating tweak-related conditions
10/23/2003WO2003086309A2 NF-κB INHIBITORS
10/23/2003WO2003086306A2 5ht2c receptor modulators
10/23/2003WO2003086294A2 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003WO2003086288A2 Bicyclic amides
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003WO2003057898A3 Methods and materials for modulating p2x2
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003057147A3 Useful aroyl pyrrole heteroaryl methanones and methanols
10/23/2003WO2003055848A3 Urea derivatives as vr1- antagonists
10/23/2003WO2003051315A3 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
10/23/2003WO2003048773A3 Methods for monitoring amyotrophic lateral sclerosis
10/23/2003WO2003040164A3 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
10/23/2003WO2003029410A3 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER
10/23/2003WO2003025130A3 Receptors and membrane-associated proteins
10/23/2003WO2003016466A3 ANTI-Aβ ANTIBODIES
10/23/2003WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
10/23/2003WO2003007872A3 Process for the preparation of citalopram hydrobromide
10/23/2003WO2002092056A8 Compaction process for manufacture of sodium phenytoin dosage form
10/23/2003WO2002081505A3 Peptide for the diagnosis and therapy of alzheimer's disease
10/23/2003WO2002079456A3 A method for the preparation of immunologically inert amniotic membranes
10/23/2003WO2002077199A3 Methods and products related to fgf dimerization
10/23/2003WO2002070646A3 Matrix stabilized enzyme crystals and methods of use
10/23/2003WO2002066494A8 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003WO2001047562A8 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
10/23/2003WO2001041751A8 Phytoestrogens for treating als
10/23/2003WO2001002567A8 16405 receptor, a g-protein coupled receptor
10/23/2003WO2001000812A8 22012, a novel human carboxypeptidase
10/23/2003US20030199728 Agent for enhancing alpha-wave appearance, an agent for inducing a relaxed state and a food or drink comprising the agent
10/23/2003US20030199701 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative
10/23/2003US20030199673 For inducing immune response and administering immunotherapy
10/23/2003US20030199589 Anticonvulsant and central nervous system-depressing bis (fluorophenyl) alkylamides and their uses
10/23/2003US20030199571 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
10/23/2003US20030199569 Pyrrolidine derivatives
10/23/2003US20030199567 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
10/23/2003US20030199562 Substituted benzoxazoles as estrogenic agents
10/23/2003US20030199555 Indoline compounds and to pharmaceutical compositions containing them
1 ... 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 ... 1833